Press Releases

Opthea Files Registration Statement for Proposed Initial Public Offering in the United States

September 25, 2020

Read More

Opthea to Host Wet AMD and DME Key Opinion Leader (KOL) Symposium on August 6, 2020 (AEST)

July 28, 2020

Read More

Opthea Reports New Data of OPT-302 in Diabetic Macular Edema at the 2020 Annual Meeting of the American Society of Retina Specialists

July 27, 2020

Read More

Corporate Presentation of Ph1b/2a DME Trial Data (ASRS)

July 25, 2020

Read More

Opthea Appoints New Non-Executive Director

July 24, 2020

Read More

Opthea Clinical Data of OPT-302 in Diabetic Macular Edema to be Presented at American Society of Retina Specialists 2020 Annual Meeting

July 23, 2020

Read More

Opthea Reports Positive Phase 2a Trial Results of OPT-302 in Diabetic Macular Edema

June 9, 2020

Read More

Opthea to Host Investor Teleconference

June 9, 2020

Read More

Opthea Completes Patient Dosing in Phase 2a DME Trial

March 30, 2020

Read More

Opthea Half Year Report and Accounts

February 26, 2020

Read More